Hepion Pharmaceuticals Inc (HEPA)

$0.14 -0.18 (-57.55%)
Market Cap 4.28M
Revenue (ttm) 0.00
Net Income (ttm) -13.19M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,907,500
Avg Vol 5,820,207
Day's Range N/A - N/A
Shares Out 10.93M
Stochastic %K 55%
Beta 1.90
Analysts Strong Buy
Price Target $30.00

Company Profile

Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatment for hepatocellular carcinoma (HCC) and other chronic liver diseases in the United States. It develops Rencofilstat, a therapeutic drug candidate that binds and inhibits the function of a specific class of isomerase enzymes called cyclophilins that regulates protein folding, as well as preclinical experiments of Rencofilstat reflects decreased liver fibrosis; liver inflammation; liver tumor burden;...

Industry: Biotechnology
Sector: Healthcare
Phone: 732 902 4000
Address:
55 Madison Avenue, Suite 400 PMB No. 4362, Morristown, United States
BADBOYROY
BADBOYROY Mar. 21 at 3:43 AM
$HEPA https://www.bioworld.com/articles/727272-farsight-medical-technology-divulges-new-inhibitors-of-cyclophilin-a-and-d?v=preview
0 · Reply
BADBOYROY
BADBOYROY Mar. 21 at 3:30 AM
$HEPA China made sure renco never saw the light of day. Now they have their own version. https://www.cell.com/cell-reports-medicine/fulltext/S2666-3791(26)00071-6
0 · Reply
Moneybucks
Moneybucks Mar. 20 at 3:28 AM
$HEPA Tick Tock Tick Tock Taco has rung the bell😂
0 · Reply
baurzhan16
baurzhan16 Mar. 19 at 6:58 PM
$HEPA
0 · Reply
prismmarketview
prismmarketview Mar. 19 at 5:05 PM
PRISM Mid-Day Movers: Space and Pharmaceuticals are Today’s Leaders. Mobix Labs (NASDAQ: $MOBX) is climbing about 25–30% as traders bet on fresh production orders for its EMI filters used in U.S. Navy Tomahawk missiles and other defense platforms. Hepion Pharmaceuticals (NASDAQ: $HEPA) is popping roughly 20% off sub‑$0.10 levels after its 10‑K confirmed it has shelved NASH drug rencofilstat and is pivoting to liver‑function diagnostics, a move the market is treating more as a trading bounce than a real turnaround. Other Notable Movers: AEye Inc. ( $LIDR) up 18% Biotricity Inc. ( $BTCY) up 14% Reviva Pharmaceuticals ( $RVPH) down -53% https://prismmarketview.com/prism-mid-day-movers-space-and-pharmaceuticals-are-todays-leaders-2/
0 · Reply
prismmarketview
prismmarketview Mar. 18 at 4:06 PM
PRISM Mid-Day Movers: Weight Loss and Biotech are Today's Leaders. Allurion Technologies ( $ALUR) is rebounding about 30% around 0.75 after an NYSE delisting notice and new FDA approval for its gastric balloon device, while ZyVersa Therapeutics ( $ZVSA) is up roughly 20% amid a volatile multi‑week surge driven by interest in its IC 100 and VAR 200 inflammatory‑disease platforms despite ongoing micro‑cap and financing risks. Other Notable Movers: Microvast Holdings ( $MVST) up 19% NUBRU Inc ( $BURU) up 16% Hepion Pharmaceuticals ( $HEPA) down -30% https://prismmarketview.com/prism-mid-day-movers-weight-loss-and-biotech-are-todays-leaders/
1 · Reply
YoungTJ
YoungTJ Mar. 18 at 1:10 PM
$HEPA nice $3000 capital loss this tax season… thanks HEPA
2 · Reply
prismmarketview
prismmarketview Mar. 17 at 4:28 PM
PRISM Mid-Day Movers: EV and AI Datacenter and Infrastructure are Today’s Leaders. AEye (NASDAQ: $LIDR) is up about 35–40% over two sessions after Q4 results showed ~$86.5M cash, no debt, and plans to cut 2026 cash burn as it shifts into commercial lidar programs. EdgeMode (OTC: $EDGM) is jumping roughly 30% as speculative money returns on its BAIF joint‑venture plan to build multi‑gigawatt AI data‑center capacity despite ongoing steep losses. Other Notable Movers: Numinus Wellness ( $NUMIF) up 28% Hepion Pharmaceuticals ( $HEPA) up 20% Comtech Communications ( $CMTL) down 27% https://prismmarketview.com/prism-mid-day-movers-ev-and-ai-datacenter-and-infrastructure-are-todays-leaders/
0 · Reply
prismmarketview
prismmarketview Mar. 10 at 4:43 PM
PRISM Mid-Day Movers: Global Health and Biotech are Today’s Leaders. Longeveron (NASDAQ: $LGVN ) is ripping ~71% as traders crowd into its stem‑cell story after Phase 2b data showed lead therapy laromestrocel improved 6‑minute walk distance by 63m in frail elderly patients and MRI biomarker work in Alzheimer’s pointed to reduced neuroinflammation, while new financing extends cash into late 2026. Polaryx Therapeutics (NASDAQ: $PLYX ) adds another ~22–23% to $3.52 as its thin float, fresh Nasdaq direct listing, Maxim $10 Buy rating, and plans for the SOTERIA Phase 2 basket trial of PLX‑200 across multiple lysosomal storage disorders keep momentum money pressing the bid. Other Notable Movers: LifeMD( $LFMD) up 20% Hepion Pharmaceuticals ( $HEPA) up 19% Allurion ( $ALUR) down -45% https://prismmarketview.com/prism-mid-day-movers-global-health-and-biotech-are-todays-leaders/
0 · Reply
Tacto
Tacto Feb. 28 at 12:55 AM
$HEPA 🙄
0 · Reply
Latest News on HEPA
No data available.
BADBOYROY
BADBOYROY Mar. 21 at 3:43 AM
$HEPA https://www.bioworld.com/articles/727272-farsight-medical-technology-divulges-new-inhibitors-of-cyclophilin-a-and-d?v=preview
0 · Reply
BADBOYROY
BADBOYROY Mar. 21 at 3:30 AM
$HEPA China made sure renco never saw the light of day. Now they have their own version. https://www.cell.com/cell-reports-medicine/fulltext/S2666-3791(26)00071-6
0 · Reply
Moneybucks
Moneybucks Mar. 20 at 3:28 AM
$HEPA Tick Tock Tick Tock Taco has rung the bell😂
0 · Reply
baurzhan16
baurzhan16 Mar. 19 at 6:58 PM
$HEPA
0 · Reply
prismmarketview
prismmarketview Mar. 19 at 5:05 PM
PRISM Mid-Day Movers: Space and Pharmaceuticals are Today’s Leaders. Mobix Labs (NASDAQ: $MOBX) is climbing about 25–30% as traders bet on fresh production orders for its EMI filters used in U.S. Navy Tomahawk missiles and other defense platforms. Hepion Pharmaceuticals (NASDAQ: $HEPA) is popping roughly 20% off sub‑$0.10 levels after its 10‑K confirmed it has shelved NASH drug rencofilstat and is pivoting to liver‑function diagnostics, a move the market is treating more as a trading bounce than a real turnaround. Other Notable Movers: AEye Inc. ( $LIDR) up 18% Biotricity Inc. ( $BTCY) up 14% Reviva Pharmaceuticals ( $RVPH) down -53% https://prismmarketview.com/prism-mid-day-movers-space-and-pharmaceuticals-are-todays-leaders-2/
0 · Reply
prismmarketview
prismmarketview Mar. 18 at 4:06 PM
PRISM Mid-Day Movers: Weight Loss and Biotech are Today's Leaders. Allurion Technologies ( $ALUR) is rebounding about 30% around 0.75 after an NYSE delisting notice and new FDA approval for its gastric balloon device, while ZyVersa Therapeutics ( $ZVSA) is up roughly 20% amid a volatile multi‑week surge driven by interest in its IC 100 and VAR 200 inflammatory‑disease platforms despite ongoing micro‑cap and financing risks. Other Notable Movers: Microvast Holdings ( $MVST) up 19% NUBRU Inc ( $BURU) up 16% Hepion Pharmaceuticals ( $HEPA) down -30% https://prismmarketview.com/prism-mid-day-movers-weight-loss-and-biotech-are-todays-leaders/
1 · Reply
YoungTJ
YoungTJ Mar. 18 at 1:10 PM
$HEPA nice $3000 capital loss this tax season… thanks HEPA
2 · Reply
prismmarketview
prismmarketview Mar. 17 at 4:28 PM
PRISM Mid-Day Movers: EV and AI Datacenter and Infrastructure are Today’s Leaders. AEye (NASDAQ: $LIDR) is up about 35–40% over two sessions after Q4 results showed ~$86.5M cash, no debt, and plans to cut 2026 cash burn as it shifts into commercial lidar programs. EdgeMode (OTC: $EDGM) is jumping roughly 30% as speculative money returns on its BAIF joint‑venture plan to build multi‑gigawatt AI data‑center capacity despite ongoing steep losses. Other Notable Movers: Numinus Wellness ( $NUMIF) up 28% Hepion Pharmaceuticals ( $HEPA) up 20% Comtech Communications ( $CMTL) down 27% https://prismmarketview.com/prism-mid-day-movers-ev-and-ai-datacenter-and-infrastructure-are-todays-leaders/
0 · Reply
prismmarketview
prismmarketview Mar. 10 at 4:43 PM
PRISM Mid-Day Movers: Global Health and Biotech are Today’s Leaders. Longeveron (NASDAQ: $LGVN ) is ripping ~71% as traders crowd into its stem‑cell story after Phase 2b data showed lead therapy laromestrocel improved 6‑minute walk distance by 63m in frail elderly patients and MRI biomarker work in Alzheimer’s pointed to reduced neuroinflammation, while new financing extends cash into late 2026. Polaryx Therapeutics (NASDAQ: $PLYX ) adds another ~22–23% to $3.52 as its thin float, fresh Nasdaq direct listing, Maxim $10 Buy rating, and plans for the SOTERIA Phase 2 basket trial of PLX‑200 across multiple lysosomal storage disorders keep momentum money pressing the bid. Other Notable Movers: LifeMD( $LFMD) up 20% Hepion Pharmaceuticals ( $HEPA) up 19% Allurion ( $ALUR) down -45% https://prismmarketview.com/prism-mid-day-movers-global-health-and-biotech-are-todays-leaders/
0 · Reply
Tacto
Tacto Feb. 28 at 12:55 AM
$HEPA 🙄
0 · Reply
MeatBallGuy
MeatBallGuy Feb. 25 at 3:20 AM
$HEPA hepa shit
0 · Reply
Pharm_Hand
Pharm_Hand Feb. 10 at 7:25 PM
$HEPA I motion for a full labiatic disclosure
1 · Reply
Pharm_Hand
Pharm_Hand Feb. 10 at 6:23 PM
$HEPA Someone unplug Labia's vibrator?
0 · Reply
Moneybucks
Moneybucks Jan. 31 at 12:29 AM
$HEPA
3 · Reply
Moneybucks
Moneybucks Jan. 30 at 4:38 PM
$HEPA Officers and Directors liability insurance ends Saturday
1 · Reply
Moneybucks
Moneybucks Jan. 27 at 4:56 PM
$HEPA https://www.ft.com/content/18ec669c-f832-4756-bc37-8cb33cb8899a
0 · Reply
Moneybucks
Moneybucks Jan. 22 at 2:24 AM
$HEPA https://stocktwits.com/news-articles/markets/equity/nasdaq-exit-doesnt-shake-retail-bulls-as-hepion-preps-for-otc-trading/chi8chARbmZ
0 · Reply
Discernment
Discernment Jan. 16 at 5:38 PM
$HEPA More like "Dr." Lootbiati, pillaging the coffers of this company while getting zero work done. Is that MD degree even real, or just a third world fake one? Every time I hear her talk she reminds me of Kamala Harris, so can't imagine there's too much going on upstairs....
1 · Reply
BADBOYROY
BADBOYROY Jan. 15 at 10:07 PM
$HEPA Libiati is the new CEO effective Jan. 8th.
2 · Reply
Moneybucks
Moneybucks Jan. 15 at 1:51 AM
$HEPA Testing Testing One Two
1 · Reply
WindyCityDreamz
WindyCityDreamz Jan. 7 at 2:12 PM
$HEPA just checking in on the biggest fraud in the market!
1 · Reply